Original Articles
30 April 2024
Vol. 18 No. 2 (2024)
Acceptance to take COVID-19 vaccine and its relation to COVID-19 infection
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
604
Views
392
Downloads
38
HTML
Authors
One of the biggest global health threats is vaccine hesitancy and it remains a global issue. The speed at which vaccines are developed and media misinformation contribute to vaccine reluctance. This study examined the relationship between vaccine acceptance and COVID-19 infection. A cross-sectional study was used with a sample of 1388 subjects including students and academic staff. Data were collected using the self-administered COVID-19 Vaccine Acceptance Behavior questionnaire, which has nine dimensions and 42 items and asks about COVID-19 infection frequency and timing. The mean COVID-19 vaccine behavior scores of hesitant subjects were low. Low trust in COVID-19 vaccines (25.4%) was the main reason for hesitancy. COVID-19 vaccine hesitancy is positively correlated with increased infection rates (P≤0.001). Acceptance of the COVID-19 vaccine can reduce infection rates, protect vulnerable populations, and aid public health efforts to control the virus.
Altmetrics
Downloads
Download data is not yet available.
Citations
Salman M, Mallhi TH, Tanveer N, et al. Evaluation of conspiracy beliefs, vaccine hesitancy, and willingness to pay towards COVID-19 vaccines in six countries from Asian and African Regions: a large multinational analysis. Vaccines 2022;10:1866. DOI: https://doi.org/10.3390/vaccines10111866
Suzuki N, Yamamoto T, Uchiumi C, Sugaya N. Socioeconomic and behavioral characteristics associated with COVID-19 vaccine hesitancy under a declared state of emergency in Japan. Brain Behav Immun Health 2022;22:100448. DOI: https://doi.org/10.1016/j.bbih.2022.100448
Yu X, Sun X, Cui P, et al. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Transbound Emerg Dis 2021;67:1697-707. DOI: https://doi.org/10.1111/tbed.13604
World Health Organization, WHO. Coronavirus disease 2019 (COVID-19): situation report, 51. Geneva: World Health Organization 2020. Available from: https://apps.who.int/iris/handle/10665/331475
Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5,700 patients hospitalized with COVID-19 in the NewYork City area. JAMA 2020 26;323:2052-9. DOI: https://doi.org/10.1001/jama.2020.6775
Tong JY, Wong A, Zhu D, et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2020;163:3-11. DOI: https://doi.org/10.1177/0194599820926473
CDC. Certain Medical Conditions and Risk for Severe COVID-19 Illness. CDC. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html#:~:text=Like%20adults%2C%20children%20with%20obesity,very%20sick%20from%20COVID%2D19. (Accessed on 10th January 2024).
Tsatsakis A, Calina D, Falzone L, et al. SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. DOI: https://doi.org/10.1016/j.fct.2020.111769
Karim SK, Taha PH, Amin NMM, et al., COVID-19-related anxiety disorder in Iraq during the pandemic: an online cross sectional study. Middle East Curr Psychiatry 2020;27:1-9. DOI: https://doi.org/10.1186/s43045-020-00067-4
Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol 2020;35:325-30. DOI: https://doi.org/10.1007/s10654-020-00634-3
Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine 2020;26:100495. DOI: https://doi.org/10.1016/j.eclinm.2020.100495
Hua J, Shaw R. Coronavirus (COVID-19) “infodemic” and emerging issues through a data lens: The case of China. Int J Environ Res Public Health 2020;17:2309. DOI: https://doi.org/10.3390/ijerph17072309
Sherman SM, Smith LE, Sim J, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother 2021;17:1612-21. DOI: https://doi.org/10.1080/21645515.2020.1846397
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine 2020;38. DOI: https://doi.org/10.1016/j.vaccine.2020.08.043
Alfageeh EI, Alshareef N, Angawi K, et al. Acceptability of a COVID-19 Vaccine among the Saudi population. Vaccines 2021;9:226. DOI: https://doi.org/10.3390/vaccines9030226
García LY, Cerda AA. Acceptance of a COVID-19 vaccine: A multifactorial consideration. Vaccine 2020;38:7587. DOI: https://doi.org/10.1016/j.vaccine.2020.10.026
Dodd RH, Cvejic E, Bonner C, et al. Willingness to vaccinate against COVID-19 in Australia. Lancet Infect Dis 2021;21:318-9. DOI: https://doi.org/10.1016/S1473-3099(20)30559-4
Furman FM, Zgliczyński WS, Jankowski M, et al., The state of vaccine confidence in Poland: A 2019 nationwide cross sectional survey. Int J Environ Res Public Health 2020;17:45-65. DOI: https://doi.org/10.3390/ijerph17124565
Almaghaslah D, Alsayari A, Kandasamy G, Vasudevan R. COVID-19 vaccine hesitancy among young adults in Saudi Arabia: a cross-sectional web-based study. Vaccines 2021;9:330. DOI: https://doi.org/10.3390/vaccines9040330
Khalid S, Usmani BA, Siddiqi S. COVID-19 vaccine hesitancy in Pakistan: a mini review of the published discourse. Front Public Health 2022;10. DOI: https://doi.org/10.3389/fpubh.2022.841842
Salman M, Mallhi TH, Khan YH, et al. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public’s intention to take booster vaccines: a cross-sectional analysis. Human Vaccines Immunother 2023;19:2225990. DOI: https://doi.org/10.1080/21645515.2023.2225990
Nerida TM. COVID-19 vaccine acceptance behavior among Hispanics/Latinxs in Nevada: a theory-based analysis. published doctoral dissertation. School of Public Health The Graduate College, University of Nevada, Las Vegas, 2022. DOI: https://doi.org/10.3390/healthcare11050688
Loomba S, de Figueiredo A, Piatek SJ, et al. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav 2021;5:337-48. DOI: https://doi.org/10.1038/s41562-021-01056-1
Yasmin F, Najeeb H, Siddiqui HF, et al. Frequency of COVID‐19 vaccine side effects and its associated factors among the vaccinated population of Pakistan: a cross‐sectional study. Health Sci Rep 2023;6:e1071. DOI: https://doi.org/10.1002/hsr2.1071
Mohamed MS, Mohamed AO, Alenazy R, et al. A first report on side-effects of COVID-19 vaccines among general population in Sudan: a cross-sectional analysis. Vaccines 2023;11:315. DOI: https://doi.org/10.3390/vaccines11020315
Algabbani F, Alomeir O, Alhussayen M, Algabbani A. Vaccine hesitancy among healthcare providers at the beginning of a pandemic: the case of COVID-19 vaccines. Saudi J Health Syst Res 2022;2:98-106. DOI: https://doi.org/10.1159/000524251
Niguse S, Gebremariam S, Terefa DR, et al. Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study. Human Vaccines Immunother 2023;19:2171181. DOI: https://doi.org/10.1080/21645515.2023.2171181
Belmin JL, Hidoux P, Drunat O, et al. First-dose coronavirus 2019 vaccination coverage among the residents of long-term care facilities in France. Gerontology 2022;68:546-50. DOI: https://doi.org/10.1159/000517793
Pokhrel T, Karki K, Tinkari B, et al. COVID-19 vaccination up-take in three districts of Nepal. Human Vaccines & Immunother 2023;19:2166321. DOI: https://doi.org/10.1080/21645515.2023.2166321
Supporting Agencies
Prince Sattam Bin Abdulaziz UniversityHow to Cite
Acceptance to take COVID-19 vaccine and its relation to COVID-19 infection. (2024). Italian Journal of Medicine, 18(2). https://doi.org/10.4081/itjm.2024.1725
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin, Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2 , Italian Journal of Medicine: Vol. 9 No. 1 (2015)
- Eleonora Pistella, Claudio Santini, Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections , Italian Journal of Medicine: Vol. 10 No. 4 (2016)
- Manuel Tufoni, Alessandra Tovoli, Caterina Maggioli, Lucia Napoli, Carmen Serena Ricci, Marianna Mastroroberto, Giacomo Zaccherini, Paolo Caraceni, A case of pneumonia and sepsis in cirrhosis as paradigm of the problems in the management of bacterial infections in cirrhosis and of the limitations of current knowledge , Italian Journal of Medicine: Vol. 7 No. 3 (2013)
- Ohoud Alhumaidan, Zeina Alkudmani, Khaled Alnafee, Sabah Alshuhri, Bandar Alrashid, Jalwa Alkahtany, Afnan Almazrua, Salem Alghamdi, Assessing the effect of implementing a central line care bundle on central line-associated bloodstream infections in a tertiary hospital in Saudi Arabia , Italian Journal of Medicine: Vol. 18 No. 4 (2024)
- Sirio Fiorino, Letizia Bacchi-Reggiani, Laura Pontoriero, Claudio Gallo, Elisabetta Chili, Michele Masetti, Nicola Zanini, Anna Grondona, Tania Silvestri, Gaia Deleonardi, Elisabetta Magrini, Roberto Motta, Adele Fornelli, Arrigo Bondi, Dario De Biase, Paola Baccarini, Giovanni Tallini, Antonio Tropeano, Andrea Cuppini, Gastone Castellani, Elio Jovine, Pancreatic carcinoma development: new etiological and pathogenetic evidence , Italian Journal of Medicine: Vol. 7 No. 4 (2013)
- Ercole Concia, Fulvia Mazzaferri, Maddalena Cordioli, New antibiotic development: barriers and opportunities , Italian Journal of Medicine: Vol. 10 No. 4 (2016)
- Bissan Elattar, Rahaf Ka’ki, Samar Alansawi, Marwan Ismail, Hassan Higazi, Salah Hussein, Sara Mohammed Ali Mohammed, Salma Elnour, Nour Farajallah, Khalid Sukar , Neutrophil-lymphocyte ratio as a biomarker for urinary tract infection in female patients at Thumbay University Hospital, Ajman, UAE , Italian Journal of Medicine: Vol. 18 No. 2 (2024)
- Gabriele Cioni, Angela Fedeli, Ginevra Bellandi, Rossella Squillante, Mauro Zuccotti, Gianluca Buffini, Atypical presentation of West Nile encephalitis: a brief report and review of the current literature , Italian Journal of Medicine: Vol. 16 No. 1 (2022)
- Fulvia Paolozzi, Pierpaolo Di Micco, Antonella Giliberti, Gianluca Latte, Maria Teresa Feola, Immacolata Gaia Paduano, Concetta Schiano, Maurizio Latte, Acute kidney failure due to varicella-zoster virus solved by early antiviral treatment based on brivudin , Italian Journal of Medicine: Vol. 19 No. 1 (2025)
- Elena Garlatti Costa, Cesare Mazzaro, Alessandro Grembiale, Alessandro Berto, Rita De Rosa, Silvia Grazioli, Maurizio Tonizzo, HIV, HCV and SARS-CoV-2: friends or foes? A case report , Italian Journal of Medicine: Vol. 15 No. 3 (2021)
You may also start an advanced similarity search for this article.